Exhibit 11
INNOVIR LABORATORIES, INC. AND SUBSIDIARIES
(A Development Stage Enterprise)
STATEMENT OF COMPUTATION OF NET LOSS PER SHARE
Three months ended March 31,
----------------------------
1997 1996
------------ ------------
Primary:
Net loss ....................................... ($ 2,497,000) ($ 549,000)
============ ============
Per share data:
Weighted average number of Common
shares outstanding during the period.. 18,042,470 9,500,000
============ ============
Net loss per share ................... ($ 0.14) ($ 0.06)
============ ============
Fully diluted:
Net loss ....................................... ($ 2,497,000) ($ 549,000)
============ ============
Per share data:
Weighted average number of Common
shares outstanding during the period.. 18,042,470 9,500,000
Shares issuable upon conversion of convertible
equity securities .................... 9,120,512 8,666,666
Shares issuable upon exercise of outstanding
options and warrants ................. 3,018,156 2,000,000
Shares assumed to be repurchased under
the treasury stock method ............ (1,981,097) (685,714)
------------ ------------
Number of common shares used in computing per
share data ........................... 28,200,041 19,480,952
============ ============
Net loss per share ........ ($ 0.09) ($ 0.03)
============ ============